In its two programs in Georgia and Abkhazia, MSF has introduced a new approach in care for patients suffering from multiple drug-resistant tuberculosis (MDR-TB) in order to alleviate what are particularly fastidious treatment conditions, our staff are now offering patients home-care.
Multiple drug-resistant tuberculosis remains a difficult illness to treat, for several reasons:
Definition: Multiple drug-resistant tuberculosis (TB-MDR) describes a case where the infected patient displays resistance to at least two of the most powerful molecules employed in first-line treatment (Rifampicine and Isionazide).
Resistance is caused by:
the administering of inadequate or incomplete treatments,
the prescribing of poor-quality medicines,
direct infection by a resistant strain of the illness.
MSF's MDR-TB Programmes:
Zugdidi (Georgia): 81 patients
Soukhoumi (Abkhazia): 51 patients